Adenosine 5'-triphosphate infusions reduced disease activity and inflammation in a patient with active rheumatoid arthritis.
Bours
Martijn J L
MJ
Peeters
Ralph H R M
RH
Landewé
Robert B M
RB
Beijer
Sandra
S
Arts
Ilja C W
IC
Dagnelie
Pieter C
PC
D000203:Activities of Daily Living; D000249:Adenosine Monophosphate / Q000008:administration & dosage / Q000031:analogs & derivatives*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D012720:Severity of Illness Index; D013873:Thionucleotides / Q000008:administration & dosage*; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D013873:Thionucleotides; C014308:adenosine 5'-phosphorothioate; D000249:Adenosine Monophosphate; D008727:Methotrexate